Estrogen receptor α gene PvuII polymorphism and coronary artery disease: A meta-analysis of 21 studies

Journal of Zhejiang University: Science B

Volumn 15, Issue 3, 2014, Pages 243-255

  Ding, Jie ^a   Xu, Hui ^b   Yin, Xiang ^a   Zhang, Fu Rong ^a   Pan, Xiao Ping ^c   Gu, Yi An ^d   Chen, Jun Zhu ^a   Guo, Xiao Gang ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b Gaozhao Street Community Health Service Center ^*  (China)

^c ZHEJIANG UNIVERSITY   (China)

^d NewYork Presbyterian Hospital   (United States)

Author keywords

Coronary artery disease (CAD); Estrogen receptor gene; Meta analysis; Polymorphism

Indexed keywords

ESTROGEN RECEPTOR ALPHA;

ARTICLE; ASIAN; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; ETHNIC DIFFERENCE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INHERITANCE; META ANALYSIS (TOPIC); PRIORITY JOURNAL; SYSTEMATIC REVIEW (TOPIC);

ASIAN CONTINENTAL ANCESTRY GROUP; CORONARY ARTERY DISEASE; ESTROGEN RECEPTOR ALPHA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ODDS RATIO; POLYMORPHISM, GENETIC;

EID: 84897094083     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B1300220     Document Type: Article

References (57)

1. Alevizaki, M., Saltiki, K., Cimponeriu, A., et al., 2007. Severity of cardiovascular disease in postmenopausal women: associations with common estrogen receptor α polymorphic variants. Eur. J. Endocrinol., 156(4): 489-496. [doi:10.1530/EJE-06-0685] (Pubitemid 46672651)
2. Almeida, S., Hutz, M.H., 2006. Estrogen receptor 1 gene polymorphisms and coronary artery disease in the Brazilian population. Braz. J. Med. Biol. Res., 39(4):447-454. [doi:10.1590/S0100-879X2006000400004]
3. Batchelor, W.B., Ellis, S.G., Ormiston, J.A., et al., 2013. Racial differences in long-term outcomes after percutaneous coronary intervention with paclitaxel-eluting coronary stents. J. Interv. Cardiol., 26(1):49-57. [doi:10.1111/j.1540-8183.2012.00760.x]
4. Begg, C.B., Mazumdar, M., 1994. Operating characteristics of a rank correlation test for publication bias. Biometrics, 50(4):1088-1101.
5. Boroumand, M., Ghaedi, M., Mohammadtaghvaei, N., et al., 2009. Association of estrogen receptor α gene polymorphism with the presence of coronary artery disease documented by coronary angiography. Clin. Biochem., 42(9):835-839. [doi:10.1016/j.clinbiochem.2009.01.005]
6. Camargo, M.C., Mera, R., Correa, P., et al., 2006. Interleukin- 1β and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol. Biomarkers Prev., 15(9):1674-1687. [doi:10.1158/1055-9965.EPI-06-0189] (Pubitemid 44497104)
7. Cheng, A.J., Fu, N.K., Xu, J., et al., 2006. A study of the correlation between estrogen receptor gene polymorphism and coronary heart disease as well as serum lipid levels in postmenopausal women. Hebei Med. J., 28(7):568-570 (in Chinese).
8. Cochran, W.G., 1968. The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics, 24(2):295-313.
9. Egger, M., Davey Smith, G., Schneider, M., et al ., 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ, 315(7109):629-634. [doi:10.1136/bmj.315.7109.629] (Pubitemid 27387172)
10. Figtree, G.A., McDonald, D., Watkins, H., et al., 2003. Truncated estrogen receptor α 46-kDa isoform in human endothelial cells: relationship to acute activation of nitric oxide synthase. Circulation, 107(1):120-126. [doi:10.1161/01.CIR.0000043805.11780.F5] (Pubitemid 36070943)
11. Figtree, G.A., Noonan, J.E., Bhindi, R., et al., 2009. Estrogen receptor polymorphisms: significance to human physiology, disease and therapy. Recent Pat. DNA Gene Seq., 3(3):164-171. [doi:10.2174/187221509789318397]
12. Grady, D., Rubin, S.M., Petitti, D.B., et al., 1992. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann. Intern. Med., 117(12):1016-1037. [doi:10.7326/0003-4819-117-12-1016]
13. Grodstein, F., Stampfer, M.J., Colditz, G.A., et al., 1997. Postmenopausal hormone therapy and mortality. N. Engl. J. Med., 336(25):1769-1775. [doi:10.1056/NEJM199706193362501]
14. Guo, Z.G., Zheng, H., Wu, S.Z., et al., 2002. Relationship between estrogen receptor gene polymorphism and coronary heart disease. Chin. J. Geriatr. Cardiovasc. Cerebrovasc. Dis., 4(6):374-377 (in Chinese).
15. Gurevitz, O., Jonas, M., Boyko, V., et al., 2000. Clinical profile and long-term prognosis of women ≤50 years of age referred for coronary angiography for evaluation of chest pain. Am. J. Cardiol., 85(7):806-809. [doi:10.1016/S0002-9149(99)00871-1] (Pubitemid 30157843)
16. Hamada, H., Kim, M.K., Iwakura, A., et al., 2006. Estrogen receptors α and β mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. Circulation, 114(21): 2261-2270. [doi:10.1161/CIRCULATIONAHA.106.631465] (Pubitemid 44789500)
17. Herrington, D.M., Howard, T.D., Brosnihan, K.B., et al., 2002. Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation, 105(16):1879-1882. [doi:10.1161/01.CIR.0000016173.98826.88] (Pubitemid 34437611)
18. Higgins, J.P., Thompson, S.G., 2002. Quantifying heterogeneity in a meta-analysis. Stat. Med., 21(11):1539-1558. [doi:10.1002/sim.1186] (Pubitemid 34746062)
19. Higgins, J.P., Thompson, S.G., Deeks, J.J., et al., 2003. Measuring inconsistency in meta-analyses. BMJ, 327(7414):557-560. [doi:10.1136/bmj.327. 7414.557] (Pubitemid 37088507)
20. Huang, X.Z., Zhang, P.A., Li, Y., et al., 2002. Association of estrogen receptor gene polymorphism with coronary heart disease. Chin. J. Cardiol., 30(2):78-81 (in Chinese).
21. Ioana, M., Ferwerda, B., Plantinga, T.S., et al., 2012. Different patterns of Toll-like receptor 2 polymorphisms in populations of various ethnic and geographic origins. Infect. Immun., 80(5):1917-1922. [doi:10.1128/IAI.00121- 12]
22. Jesmin, S., Mowa, C.N., Sultana, S.N., et al., 2010. VEGF signaling is disrupted in the hearts of mice lacking estrogen receptor alpha. Eur. J. Pharmacol., 641(2-3):168-178. [doi:10.1016/j.ejphar.2010.05.020]
23. Jin, L.Z., Chen, X.C., Ma, Y.D., et al., 2010. Association of estrogen receptor α gene PvuII and XbaI polymorphisms with coronary artery disease. Chin. J. Biomed. Eng., 16(2):136-139 (in Chinese).
24. Jneid, H., 2012. The 2012 ACCF/AHA focused update of the unstable angina/non-ST-elevation myocardial infarction (UA/NSTEMI) guideline: a critical appraisal. Methodist Debakey Cardiovasc. J., 8(3):26-30.
25. Karadaǧ, B., Güven, M., Haciog{combining breve}lu, Y., et al., 2009. Relationship between two estrogen receptor-α gene polymorphisms and angiographic coronary artery disease. Anadolu Kardiyol. Derg., 9(4):267-272.
26. Kjaergaard, A.D., Ellervik, C., Tybjærg-Hansen, A., et al., 2007. Estrogen receptor α polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross- sectional, cohort, and case-control studies and a meta-analysis. Circulation, 115(7):861-871. [doi:10.1161/ CIRCULATIONAHA.106.615567] (Pubitemid 46294727)
27. Klos, K.L., Boerwinkle, E., Ferrell, R.E., et al., 2008. ESR1 polymorphism is associated with plasma lipid and apolipoprotein levels in Caucasians of the Rochester Family Heart Study. J. Lipid Res., 49(8):1701-1706. [doi:10.1194/jlr.M700490-JLR200]
28. Koch, W., Hoppmann, P., Pfeufer, A., et al., 2005. No replication of association between estrogen receptor α gene polymorphisms and susceptibility to myocardial infarction in a large sample of patients of European descent. Circulation, 112(14):2138-2142. [doi:10.1161/CIRCU LATIONAHA.105.545913] (Pubitemid 41475807)
29. Kunnas, T.A., Laippala, P., Penttilä, A., et al., 2000. Association of polymorphism of human α oestrogen receptor gene with coronary artery disease in men: a necropsy study. BMJ, 321(7256):273-274. [doi:10.1136/bmj.321. 7256.273] (Pubitemid 30487465)
30. Labonté, B., Suderman, M., Maussion, G., et al., 2012. Genome-wide epigenetic regulation by early-life trauma. Arch. Gen. Psychiatry, 69(7):722-731. [doi:10.1001/archgenpsychiatry.2011.2287]
31. Li, L.H., Zhao, F.M., Li, G.Q., et al., 2006. Association between estrogen receptor alpha gene variation and risks of cardiovascular disease. Mol. Cardiol. China, 6(2):90-94 (in Chinese).
32. Liu, H., Pedram, A., Kim, J.K., 2011. Oestrogen prevents cardiomyocyte apoptosis by suppressing p38α-mediated activation of p53 and by down-regulating p53 inhibition on p38β. Cardiovasc. Res., 89(1):119-128. [doi:10.1093/cvr/cvq265]
33. Lluís-Ganella, C., Lucas, G., Subirana, I., et al., 2009. Qualitative assessment of previous evidence and an updated meta-analysis confirms lack of association between the ESR1 rs2234693 (PvuII) variant and coronary heart disease in men and women. Atherosclerosis, 207(2):480-486. [doi:10.1016/j.atherosclerosis.2009.05.038]
34. Lu, H., Higashikata, T., Inazu, A., et al., 2002. Association of estrogen receptor-α gene polymorphisms with coronary artery disease in patients with familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol., 22(5):817-823. [doi:10.1161/01.ATV.0000014424.18209.21]
35. Mansur, A.P., Nogueira, C.C.M., Strunz, C.M.C., et al., 2005. Genetic polymorphisms of estrogen receptors in patients with premature coronary artery disease. Arch. Med. Res., 36(5):511-517. [doi:10.1016/j.arcmed.2005.04.002] (Pubitemid 41140058)
36. Matsubara, Y., Murata, M., Kawano, K., et al., 1997. Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels. Arterioscler. Thromb. Vasc. Biol., 17(11):3006-3012. [doi:10.1161/01.ATV.17.11. 3006] (Pubitemid 28016053)
37. Mendelsohn, M.E., Karas, R.H., 2005. Molecular and cellular basis of cardiovascular gender differences. Science, 308(5728):1583-1587. [doi:10.1126/science.1112062] (Pubitemid 40807497)
38. Peter, I., Shearman, A.M., Zucker, D.R., et al., 2005. Variation in estrogen-related genes and cross-sectional and longitudinal blood pressure in the Framingham Heart Study. J. Hypertens., 23(12):2193-2200. [doi:10.1097/01.hjh.0000188728.66183.92] (Pubitemid 41666749)
39. Rokach, A., Pollak, A., Rosen, L., et al., 2005. Estrogen receptor α gene polymorphisms are associated with the angiographic extent of coronary artery disease. J. Clin. Endocrinol. Metab., 90(12):6556-6560. [doi:10.1210/jc.2005-0236] (Pubitemid 41759315)
40. Rossouw, J.E., Anderson, G.L., Prentice, R.L., et al., 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA, 288(3):321-333. [doi:10.1001/jama.288.3.321] (Pubitemid 34761611)
41. Schuit, S.C.E., Oei, H.H., Witteman, J.C.M., et al., 2004. Estrogen receptor α gene polymorphisms and risk of myocardial infarction. JAMA, 291(24):2969-2977. [doi:10.1001/jama.291.24.2969] (Pubitemid 38802686)
42. Shearman, A.M., Cupples, L.A., Demissie, S., et al., 2003. Association between estrogen receptor α gene variation and cardiovascular disease. JAMA, 290(17):2263-2270. [doi:10.1001/jama.290.17.2263] (Pubitemid 37430558)
43. Shen, C., Chen, J., Fan, S., et al., 2012. Association between the polymorphism of estrogen receptor α and coronary artery disease in a Chinese population. Eur. J. Intern. Med., 23(2):175-178. [doi:10.1016/j.ejim. 2011.05.006]
44. Stampfer, M.J., Colditz, G.A., 1991. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev. Med., 20(1):47-63. [doi:10.1016/0091-7435(91)90006-P]
45. St-Hilaire, S., Mandal, R., Commendador, A., et al., 2011. Estrogen receptor positive breast cancers and their association with environmental factors. Int. J. Health Geogr., 10:32. [doi:10.1186/1476-072X-10-32]
46. Tang, Z.Z., Li, X.P., Yang, J.H., et al., 2008. Relationship of estrogen receptor α gene polymorphism and risk of cardiovascular diseases. Mil. Med. J. South China, 22(2): 35-37 (in Chinese).
47. 2- adrenoceptor polymorphisms and asthma: a HuGE review. Am. J. Epidemiol., 162(3):201-211. [doi:10.1093/aje/kwi184]
48. Thomas, K.L., Honeycutt, E., Shaw, L.K., et al., 2010. Racial differences in long-term survival among patients with coronary artery disease. Am. Heart J., 160(4):744-751. [doi:10.1016/j.ahj.2010.06.014]
49. Tunstall-Pedoe, H., Kuulasmaa, K., Mähönen, M., et al., 1999. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations. Lancet, 353(9164):1547-1557. [doi:10.1016/S0140-6736(99)04021-0] (Pubitemid 29219203)
50. Wang, F., He, Q., Sun, Y., et al., 2010. Female adult mouse cardiomyocytes are protected against oxidative stress. Hypertension, 55(5):1172-1178. [doi:10.1161/HYPERTENSIONAHA.110.150839]
51. Wei, C.D., Zheng, H.Y., Wu, W., et al., 2013. Meta-analysis of the association of the rs2234693 and rs9340799 polymorphisms of estrogen receptor alpha gene with coronary heart disease risk in Chinese Han population. Int. J. Med. Sci., 10(4):457-466. [doi:10.7150/ijms.5234]
52. Wright, R.S., Anderson, J.L., Adams, C.D., et al., 2011. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol., 57(19):e215-e367. [doi:10.1016/j.jacc.2011.02.011]
53. Xu, H., Hou, X., Wang, N., et al., 2008. Gender-specific effect of estrogen receptor-1 gene polymorphisms in coronary artery disease and its angiographic severity in Chinese population. Clin. Chim. Acta, 395(1-2):130-133. [doi:10.1016/j.cca.2008.06.004]
54. Yaich, L., Dupont, W.D., Cavener, D.R., et al ., 1992. Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood. Cancer Res., 52(1):77-83.
55. Yilmaz, A., Menevse, S., Erkan, A.F., et al., 2007. The relationship of the ESR1 gene polymorphisms with the presence of coronary artery disease determined by coronary angiography. Genet. Test., 11(4):367-371. [doi:10.1089/gte.2007.0019]
56. Yu, Q., Liu, E.Q., Zhao, S.H., et al., 2012. Association between TaqIB polymorphism of cholesteryl ester transfer protein and coronary artery disease in the Chinese population. J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.), 13(5):342-347. [doi:10.1631/jzus.B1100264]
57. Zheng, H.M., 2002. Association of Estrogen Receptor (ER) Polymorphisms with Coronary Artery Disease and the Lipoprotein Metabolism in Women. MS Thesis, Hebei Medical University, Hebei, China (in Chinese).